Prof Dr Mansyur Arif received his medical degree in 1989, certification of Clinical Pathology in 1998, and Consultant of Clinical Pathology in 2007 from Hasanuddin University. He completed his Doctor of Philosophy (PhD) research course in Haematology and Oncology from Hiroshima University, Japan in 1997. He also received his Master of Health specialised in hospital administrations in 2019.

Prof Mansyur was the Secretary of the Clinical Pathology Department at Hassanuddin University from 2000 to 2004. Later he became Head of Clinical Pathology for 11 years. He was also the Chairman of Intern Monitoring Unit from 2009 to 2016 at the same university. During that period, Prof Mansyur was the Vice Chairman of the medical committee in Dr. Wahidin Sudirohusodo General Hospital. He later spent 5 years as Director of Medical, Nursing and Support Services at Dr. Wahidin Sudirohusodo General Hospital. Currently, he is the Hospital Director of Dr. Tadjuddin Chalid General Hospital and has been lecturing at Hasanuddin University since 1990.

Abstract

As automation has evolved in the haematology laboratory, high throughput, greater reliability, and accuracy in results have been achieved. As well as the ability to characterise blood cells in more detail for tangible benefits and clinical value in patient management and care. The automated haematology analysers are being routinely used for complete blood count (CBC) and differential leukocyte analysis. Modern haematologic instruments include many additional parameters that provide more detailed information for clinicians and laboratory professionals, such as nucleated red blood cells, immature granulocytes, immature platelet fraction, as well as new parameters for the detection of ineffective erythropoiesis (reticulocyte haemoglobin), etc. Unfortunately, the application of these features are not used to their full potential due to lack of knowledge and understanding. The primary aim of this topic is to update the information on new parameters reported alongside CBC and differential leukocyte analysis, and to review the possible clinical applications of these parameters provided by automated haematology analysers of the XN series. On this occasion, we will describe the use of haematological parameters, namely IPF in patients with sepsis and Ret He in chronic kidney disease patients.